Delivery Order SPE2DB24D2216-SPE2DB25FGPUT
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $116,264.96 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the company's...
- The Defense Logistics Agency (DLA) awarded a $47,507.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) to be delivered by September 10, 2025. This non-set-aside competitive award leverages AmerisourceBergen's position as a critical pharmaceutical distributor supporting federal medical procurement needs. The contract was awarded on September 9, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $10,745.91. This firm fixed-price delivery order is set to be completed by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made on a non-set-aside, competitive basis. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $18,140.70 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed price contract type. This competitive award, issued on August 28, 2025, with an ultimate completion date of August 29, 2025, carries no set-aside designation. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and primary distribution...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,489.84 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed-price contract. This competitively awarded, non-set-aside delivery order was executed on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) with a ceiling value of $15,344.91. This firm fixed-price contract, which utilizes no set-aside designation, represents a competitive award and is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,468.68 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on August 25, 2025, with completion scheduled for August 26, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $53,486.83 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) under a firm fixed-price contract. The award was made on September 10, 2025, with an ultimate completion date of September 11, 2025. This non-set-aside delivery order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, and represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $1,861.15. This firm fixed-price delivery order, which is due for completion by September 4, 2025, represents a continuation of AmerisourceBergen's role as a pharmaceutical supplier to the federal government. The award carries no set-aside designation, indicating it was competitively awarded....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $42,260.33 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) under a firm fixed-price contract. The award, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania—the same location designated as the place of performance—is a major pharmaceutical...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGPUTDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $58,364.49 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) under a firm fixed price contract. The award was issued on September 16, 2025, with an ultimate completion date of September 17, 2025, and involves delivery to Conshohocken, Pennsylvania. This competitive award includes no set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and healthcare systems. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive prime vendor agreement valued at $999,999,999.00 and running through December 2026. This global pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of medications and medical commodities to support military healthcare programs worldwide. The company serves as a major distributor within the federal medical procurement framework, providing brand-name and generic medications, including diabetes treatments, to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $58.4k | 9/16/25 |